CYTOKINETICS, INCORPORATED Accounts Receivable, Related Parties, Current
CYTOKINETICS, INCORPORATED (CYTK) had Accounts Receivable, Related Parties, Current of $910.00 thousand as of 2017-03-31, per its 10-Q filed 2017-05-04.
Discontinued › Notes › Receivables
us-gaap:AccountsReceivableRelatedPartiesCurrent · last filed 2017-05-04
- 2017-03-31: Accounts Receivable, Related Parties, Current $910.00K.
- 2016-12-31: Accounts Receivable, Related Parties, Current $24.00K.
- 2016-09-30: Accounts Receivable, Related Parties, Current $67.00M.
- 2016-06-30: Accounts Receivable, Related Parties, Current $26.00K.
| Period end | Accounts Receivable, Related Parties, Current |
|---|---|
| 2017-03-31 | $910.00K 10-Q · filed 2017-05-04 |
| 2016-12-31 | $24.00K 10-Q · filed 2017-05-04 |
| 2016-09-30 | $67.00M 10-Q/A · filed 2016-12-15 |
| 2016-06-30 | $26.00K 10-Q · filed 2016-08-04 |
| 2016-03-31 | $0.00 10-Q · filed 2016-05-05 |
| 2015-12-31 | $12.00K 10-K · filed 2017-03-06 |
| 2015-09-30 | $47.00K 10-Q · filed 2015-11-05 |
| 2015-06-30 | $4.00K 10-Q · filed 2015-08-05 |
| 2015-03-31 | $970.00K 10-Q · filed 2015-05-04 |
| 2014-12-31 | $46.65M 10-K · filed 2016-03-03 |
| 2014-09-30 | $1.19M 10-Q · filed 2014-11-06 |
| 2014-06-30 | $319.00K 10-Q · filed 2014-08-07 |
| 2014-03-31 | $2.12M 10-Q · filed 2014-05-07 |
| 2013-12-31 | $5.00K 10-K · filed 2015-03-06 |
| 2013-03-31 | $328.00K 10-Q · filed 2013-05-08 |
| 2012-12-31 | $4.00K 10-K · filed 2014-03-07 |
| 2012-06-30 | $3.00K 10-Q · filed 2012-08-06 |
| 2012-03-31 | $83.00K 10-Q · filed 2012-05-04 |
| 2011-12-31 | $14.00K 10-K · filed 2013-03-15 |
| 2011-09-30 | $116.00K 10-Q · filed 2011-11-04 |
| 2011-06-30 | $27.00K 10-Q · filed 2011-08-04 |
| 2010-12-31 | $46.00K 10-K · filed 2012-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 |